comparemela.com

Latest Breaking News On - Prnewswire abbott - Page 1 : comparemela.com

Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook

Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign

- Abbott, Real Madrid and the Real Madrid Foundation launch Beat Malnutrition campaign as part of a sustained collaboration urging communities to work.

India
Colombia
Philippines
Israel
Kenya
Brazil
Mexico
United-states
Madrid
Spain
Ann-smith
Prnewswire-abbott

Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies

/PRNewswire/ Abbott (NYSE: ABT) today announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in.

Boston
Massachusetts
United-states
Australia
California
Canada
Michael-dale
Feops-heartguide
Abbott-triclip
Prnewswire-abbott
Abbott-mitraclip
Jason-rogers

Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies

/PRNewswire/ Abbott (NYSE: ABT) today announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in.

Boston
Massachusetts
United-states
Australia
California
Canada
Michael-dale
Feops-heartguide
Abbott-triclip
Prnewswire-abbott
Abbott-mitraclip
Jason-rogers

Abbott Reports First-Quarter 2021 Results

Share this article Share this article ABBOTT PARK, Ill., April 20, 2021 /PRNewswire/ Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2021. First-quarter sales of $10.5 billion increased 35.3 percent on a reported basis and 32.9 percent on an organic basis, which excludes the impact of foreign exchange. First-quarter GAAP diluted EPS was $1.00 and adjusted diluted EPS, which excludes specified items, was $1.32, reflecting 103.1 percent growth versus the prior year. 1 Abbott projects full-year 2021 diluted EPS from continuing operations on a GAAP basis of at least $3.74. Projected full-year adjusted diluted EPS from continuing operations of at least $5.00 remains unchanged and reflects growth of more than 35 percent versus the prior year.

Brazil
China
India
Russia
Abbott-binax
Prnewswire-abbott
Robertb-ford
Linkedin
Us-centers-for-medicare-medicaid-services
Facebook
Drug-administration
Core-laboratory-diagnostics

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.